Efficacy and safety of elbasvir/grazoprevir for Japanese patients with genotype 1b chronic hepatitis C complicated by chronic kidney disease, including those undergoing hemodialysis: A post hoc analysis of a multicenter study: Elbasvir/Grazoprevir for Hepatitis C
Journal article published in 2018 by
Masanori Atsukawa,
Akihito Tsubota,
Hidenori Toyoda 
,
Koichi Takaguchi,
Chisa Kondo,
Tomomi Okubo,
Atsushi Hiraoka,
Kojiro Michitaka,
Shinichi Fujioka,
Haruki Uojima ,
Tsunamasa Watanabe,
Hiroki Ikeda ,
Toru Asano,
Toru Ishikawa,
Yoshihiro Matsumoto
and other authors.
,
Koichi Takaguchi,
Chisa Kondo,
Tomomi Okubo,
Atsushi Hiraoka,
Kojiro Michitaka,
Shinichi Fujioka,
Haruki Uojima ,
Tsunamasa Watanabe,
Hiroki Ikeda ,
Toru Asano,
Toru Ishikawa,
Yoshihiro Matsumoto
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 